Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children

1998243 citationsJournal Article

Authors

Antonia Kolokathis · Jacobson Holman (United States)

M. Campbell · Jacobson Holman (United States)

Gail H. Cassell · Jacobson Holman (United States)

Margaret R. Hammerschlag · Jacobson Holman (United States)

Abstract

Azithromycin used once daily for 5 days produced a satisfactory therapeutic outcome similar to those of amoxicillin/clavulanate or erythromycin given three times a day for 10 days for treatment of community-acquired pneumonia. Azithromycin had significantly fewer side effects than comparator drugs.

Topics & Keywords

Pneumonia and Respiratory Infections Pneumocystis jirovecii pneumonia detection and treatment Bacterial Infections and Vaccines

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Pediatric Infectious Disease Journal

Volume 17, Issue 10, pp. 865-871

DOI: 10.1097/00006454-199810000-00004

Field-Weighted Citation Impact: 11.12